Business Insider23d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...
GEN23d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
The Montreal-based C3i Center obtained regulatory approval from the European Medicine Agency (EMA) to produce cell therapy therapies for the European market. The company obtained a certificate of ...
Canadian Manufacturing23d
C3i to manufacture cell therapy products for European market
C3i also obtains a certificate of GMP compliance. MONTRÉAL — C3i Center obtains regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the European ...
The National Law Review23d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
C3i, therefore, obtains a certificate of GMP (Good Manufacturing Practice) compliance, enabling it to make innovative medicines available to European patients. Last year, C3i became the first ...
Financial Post23d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) — C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...
Finanznachrichten22d
Centre C3i Inc.: C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
C3i, therefore, obtains a certificate of GMP (Good Manufacturing Practice) compliance, enabling it to make innovative medicines available to European patients. Last year, C3i became the first ...